These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 23460984)

  • 1. Reply: To PMID 22623561.
    Tanaka T; Sakaguchi H; Kichikawa K
    AJR Am J Roentgenol; 2013 Feb; 200(2):468. PubMed ID: 23460984
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of unresectable pancreatic cancer.
    Hall FM
    AJR Am J Roentgenol; 2013 Feb; 200(2):467. PubMed ID: 23345373
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of capecitabine use in patients with liver dysfunction.
    Saif MW; Tejani MA
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):730-2; discussion 736. PubMed ID: 17982413
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiogenesis: a sudden rush of blood to the tumour.
    Villanueva MT
    Nat Rev Cancer; 2015 Mar; 15(3):135. PubMed ID: 25652345
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral fluoropyrimidines: are they the equivalent of parenteral infusional 5-fluorouracil?
    Lokich J
    Cancer Invest; 2001; 19(8):854-7. PubMed ID: 11768039
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intravenous continuous infusion of fluorouracil for treatment of metastatic colorectal cancer].
    Hosokawa A
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():352-5. PubMed ID: 14574911
    [No Abstract]   [Full Text] [Related]  

  • 7. Complete remission of a metastatic neuroendocrine tumor of the pancreas with capecitabine (Xeloda) monotherapy.
    Fürstenberger G; Schmid P; Duquesne A; Ammann M; Senn HJ
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):347-8. PubMed ID: 17896108
    [No Abstract]   [Full Text] [Related]  

  • 8. [Healing for more patients].
    Arnold D
    Krankenpfl J; 2005; 43(4-6):138. PubMed ID: 16171080
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral fluoropyrimidines in colorectal cancer.
    Van Cutsem E; Peeters M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039
    [No Abstract]   [Full Text] [Related]  

  • 10. Capecitabine dosing is not yet optimized for breast cancer.
    Hudis C; Traina T; Norton L
    Ann Oncol; 2010 Nov; 21(11):2291; author reply 2291-2. PubMed ID: 20501505
    [No Abstract]   [Full Text] [Related]  

  • 11. In reply to Ren et al.
    Passoni P; Reni M; Cattaneo GM; Slim N; Cereda S
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):431-2. PubMed ID: 24837892
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.
    Mayer RJ
    J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576
    [No Abstract]   [Full Text] [Related]  

  • 13. Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study.
    Morganti AG; Picardi V; Ippolito E; Massaccesi M; Macchia G; Deodato F; Mattiucci GC; Caravatta L; Di Lullo L; Giglio G; Tambaro R; Mignogna S; Caprino P; Ingrosso M; Sofo L; Cellini N; Valentini V
    Acta Oncol; 2010 May; 49(4):418-22. PubMed ID: 20397772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral fluoropyrimidines in cancer treatment.
    Lewis NL; Meropol NJ
    Cancer Invest; 2000; 18(8):747-60. PubMed ID: 11107445
    [No Abstract]   [Full Text] [Related]  

  • 15. Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Con: Pumpin' FU (or, avoiding that oral fixation).
    Hochster HS
    Clin Adv Hematol Oncol; 2005 May; 3(5):405-6. PubMed ID: 16167014
    [No Abstract]   [Full Text] [Related]  

  • 16. Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function.
    Saadati H; Saif MW
    JOP; 2008 May; 9(3):354-6. PubMed ID: 18469454
    [No Abstract]   [Full Text] [Related]  

  • 17. Improvement of capecitabine antitumoral activity by melatonin in pancreatic cancer.
    Ruiz-Rabelo J; Vázquez R; Arjona A; Perea D; Montilla P; Túnez I; Muntané J; Padillo J
    Pancreas; 2011 Apr; 40(3):410-4. PubMed ID: 21178648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in advanced pancreatic adenocarcinoma.
    Kollmannsberger C; Peters HD; Fink U
    Cancer Treat Rev; 1998 Apr; 24(2):133-56. PubMed ID: 9728423
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine.
    Endrizzi BT; Lee PK
    Dermatol Surg; 2009 Oct; 35(10):1567-72. PubMed ID: 19681993
    [No Abstract]   [Full Text] [Related]  

  • 20. Defining the optimal schedule of drug administration: art or science?
    Twelves CJ
    J Clin Oncol; 2008 Apr; 26(11):1781-2. PubMed ID: 18398142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.